Yixin Group Ltd
HKEX:2858
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Yixin Group Ltd
Cash Equivalents
Yixin Group Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yixin Group Ltd
HKEX:2858
|
Cash Equivalents
ÂĄ3.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
FinVolution Group
NYSE:FINV
|
Cash Equivalents
ÂĄ6.2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Lufax Holding Ltd
NYSE:LU
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MoneyLion Inc
NYSE:ML
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
360 DigiTech Inc
NASDAQ:QFIN
|
Cash Equivalents
ÂĄ5.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Anhui Xinli Finance Co Ltd
SSE:600318
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yixin Group Ltd's Cash Equivalents?
Cash Equivalents
3.5B
CNY
Based on the financial report for Dec 31, 2023, Yixin Group Ltd's Cash Equivalents amounts to 3.5B CNY.
What is Yixin Group Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
10%
Over the last year, the Cash Equivalents growth was 1%. The average annual Cash Equivalents growth rates for Yixin Group Ltd have been 9% over the past three years , 10% over the past five years .